azd-1981

Small moleculeexperimental

Clinical trial activity

15 trials · 7 clinical orgs · 0 marketing orgs

Phase 1
10
Phase 2
5
Phase 3
0
Phase 4
0

Earliest trial started May 1, 2008 (NCT00690482)

Timeline

2000s

  1. Jan 1, 2008

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2008

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

CC(=O)Nc1cccc2c1c(Sc1ccc(Cl)cc1)c(C)n2CC(=O)O
Mol. weight
388.88 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Achiral Molecule
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • azd1981
  • azd1981
  • azd1981
  • azd-1981
  • azd-1981
  • azd-1981

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02031679Phase 2Jan 1, 2014AstraZeneca, Johns Hopkins University
NCT01311635Phase 1Apr 1, 2011AstraZeneca, IQVIA
NCT01254461Phase 1Feb 1, 2011AstraZeneca
NCT01265641Phase 1Jan 1, 2011AstraZeneca
NCT01196689Phase 1Oct 1, 2010AstraZeneca
NCT01199341Phase 1Oct 1, 2010AstraZeneca, IQVIA
NCT01197794Phase 2Oct 1, 2010AstraZeneca
NCT01110525Phase 1May 1, 2010AstraZeneca, IQVIA
NCT01058447Phase 1Feb 1, 2010AstraZeneca
NCT00918398Phase 1Jun 1, 2009AstraZeneca, IQVIA
NCT00859352Phase 1Mar 1, 2009AstraZeneca
NCT00766415Phase 2Nov 1, 2008AstraZeneca, Fraunhofer
NCT00758589Phase 2Sep 1, 2008AstraZeneca, University of Lodz
NCT00698282Phase 1Aug 1, 2008AstraZeneca, Chiltern International
NCT00690482Phase 2May 1, 2008AstraZeneca, University of Copenhagen
Showing 15 of 15 trials
Page 1 / 1

Organizations

Research & Development (7)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
AstraZenecaFor profit151422008
IQVIAFor profit4012009
Chiltern InternationalFor profit1012008
FraunhoferFor profit1012008
Johns Hopkins UniversityAcademic/Hospital1112014
University of CopenhagenAcademic/Hospital1012008
University of LodzAcademic/Hospital1012008
7 organizations
Page 1 / 1